Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IoM Medication Errors Committee Convenes July 6-8

This article was originally published in The Pink Sheet Daily

Executive Summary

CDER officials Jenkins, Holquist and Abrams are among the FDA panelists at three-day IoM committee meeting. Senate Finance and Health Committees staff directors and industry reps also are on the agenda.

Regulatory, legislative and industry perspectives on medication errors will be presented at the Institute of Medicine's Committee on Identifying & Preventing Medication Errors meeting July 6-8 in Washington, D.C.

FDA panelists include Office of New Drugs Director John Jenkins, Medication Errors Division Director Carol Holquist, and Office of Pharmacoepidemiology & Statistical Science Director Paul Seligman.

Additional FDA speakers are Office of Pediatric Therapeutics Director Dianne Murphy and Division of Drug Marketing, Advertising & Communications Director Tom Abrams.

The IoM committee is directed by the Medicare Modernization Act of 2003 to investigate medication errors and recommend programs for prevention. The group is slated to issue final recommendations by Jan. 1, 2007. The upcoming meeting marks the group's third session.

An industry panel comprises Johnson & Johnson Clinical Affairs VP Mike Kafrissen, Cardinal Health/Alaris Center for Medication Safety & Clinical Improvement Clinical Director Tim Vanderveen, Thomson Micromedex Chief Clinical Informatics Officer Jerry Osheroff and Healthvision Chief Medical Officer/Senior VP Jonathan Teich.

The industry panelists represent the perspectives of the pharmaceutical industry, medical device industry, pharmacy databases and e-prescribing technology, respectively.

An additional stakeholder panel features Express Scripts Chief Medical Officer Ed Weisbart, who will represent pharmacy benefit managers.

Senate Finance Committee Majority Staff Health Policy Director Mark Hayes and Minority Staff member David Schwartz will discuss drug safety and medication management initiatives. Senate Health Committee Majority Health Policy Advisor Stephen Northrup and Minority Staff Director David Bowen will discuss patient safety, quality improvement and heath information technology initiatives.

[Editor's Note: For the most current information on this and other events, visit "The Pink Sheet" DAILY's Daybook, updated throughout the day.]

- Salla Hauvonen

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS062518

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel